The Medical Benefits Of Cannabis: What You Need To Know

By Author: MarketsandMarkets
Total Articles: 281
Comment this article

The global cannabis market size is estimated to be valued at USD 27.7 billion in 2022 and is projected to reach USD 82.3 billion by 2027, recording a CAGR of 24.3% in terms of value.

Download PDF brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=201768301

The growth of the cannabis market is being driven by several factors, including:

• The increasing legalization of cannabis: The number of countries that have legalized cannabis for either medical or recreational use has been increasing in recent years. This has led to an increase in the demand for cannabis products.

• The growing awareness of the medical benefits of cannabis: There is a growing body of research that suggests that cannabis can be effective in treating a variety of medical conditions, including chronic pain, nausea, and seizures. This has led to an increase in the demand for cannabis products for medical use.

• The increasing popularity ...
... of cannabis-infused products: Cannabis-infused products, such as edibles, beverages, and topicals, are becoming increasingly popular. This is since these products offer a more discreet and convenient way to consume cannabis.

The cannabis market is segmented by product type, application, and region. By product type, the market is segmented into flowers, concentrates, and edibles. By application, the market is segmented into medical and recreational. By region, the market is segmented into North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=201768301

North America is the largest market for cannabis, followed by Europe and Asia-Pacific. The North American market is being driven by the legalization of cannabis in Canada and the United States. The European market is being driven by the legalization of cannabis in several countries, such as Germany, Italy, and Portugal. The Asia-Pacific market is being driven by the growing demand for cannabis products in countries such as China, India, and Japan.

This report includes a study on the marketing and development strategies, along with the product portfolios of leading companies. It consists of profiles of leading companies, such as Canopy Growth Corporation (Canada), Aurora Cannabis Inc. (Canada), VIVO Cannabis Inc. (Canada), Tilary Inc. (US), Unrivaled Brand Inc. (US), HEXO Corp. (Canada), Medical Marijuana Inc. (US), The Cronos Group (Canada), Medmen Enterprise Inc. (US), Cresco Labs (US), Curaleaf Holdings Inc. (US), Organigram Holdings Inc. (Canada), Stenocare (Denmark), Trulieve (US), and Indiva (Canada).

The cannabis market is a dynamic and growing market. The market is expected to continue to grow in the coming years, driven by the increasing legalization of cannabis, the growing awareness of the medical benefits of cannabis, and the increasing popularity of cannabis-infused products.